Incepta Pharmaceuticals has brought a generic version of the drug Sovaldi, of the Gilead Sciences, which is being used in treatment of hepatitis C, is a very popular drug. The generic version of the drug will be sold at a price of $10.

The generic drug of Sovaldi is named as Hopetavir and the cost of the drug for a period of 12 weeks will be $900. Cost of Gilead Sciences Inc.'s Sovaldi is very high. "Gilead is aware of unauthorized generic versions of sofosbuvir being offered in the marketplace .We're focused on enabling our eleven Indian generic partners to launch their authorized generic versions as soon as possible", the company said in an e-mail.

So far, it was the most successful drug for treating hepatitis C. And the cost of this drug for a period of twelve weeks was $86,000.

And because of high price of the drug, Gilead Sciences Inc. was criticized a lot. Harvoni, another drug manufactured by Gilead Sciences Inc., is even more expensive as it is sold at $94,500 for 12 weeks.

The high cost of these drugs creates problem for many people who are not able to afford them. Many people throughout the world suffer from Hepatitis C and developing countries face more problems. And the higher price associated with drugs makes it difficult for these countries to deal with the disease.

Therefore, need of a generic version of the drug was felt, so that people who can't afford the costly drugs could also get proper treatment.

According to statistics, about 150 million people in the world are affected by Hepatitis C and out of these, majority of people are from developing or under developed countries.